DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Carisoprodol and Aspirin (Carisoprodol / Aspirin) - Summary

 
 



SUMMARY

Carisoprodol and Aspirin Tablets, USP
mg/325 mg
Rx Only

Carisoprodol and Aspirin tablets, USP are a fixed-dose combination product containing the following two products:

  • 200 mg of carisoprodol, a centrally-acting muscle relaxant
  • 325 mg of aspirin, an analgesic with antipyretic and anti-inflammatory properties
It is available as a two-layered, Red and White, round tablet for oral administration.

Carisoprodol and Aspirin is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Carisoprodol and Aspirin should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration (see DOSAGE AND ADMINISTRATION).


See all Carisoprodol and Aspirin indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Carisoprodol and Aspirin (Carisoprodol / Aspirin)

American Academy of Pain Management Gets a New Name
Source: Medscape Anesthesiology Headlines [2016.09.22]
The American Academy of Pain Management has now become the Academy of Integrative Pain Management, to better reflect the direction pain medicine is taking.
Medscape Medical News

Sleep is key to curing chronic pain
Source: Pain / Anesthetics News From Medical News Today [2016.09.22]
I won't be able to cope with my pain if I don't sleep well' - research from the University of Warwick reveals that the way chronic pain patients think about pain and sleep leads to insomnia and...

Cara Therapeutics to Present Novel Kappa Opioid Receptor Agonist Research at Upcoming Pain Summit
Source: Conferences News From Medical News Today [2016.09.21]
Cara Therapeutics has recently resumed clinical trials for its novel kappa opioid receptor agonist CR845 in managing acute and chronic pain.

NeuroBreak: Politics of Pain; Pot for Autism
Source: MedPage Today Neurology [2016.09.20]
(MedPage Today) -- News and commentary from the world of neurology and neuroscience

Even at Cancer Centers, Finding Relief for Pain Can Be Tough
Source: MedicineNet Cancer Specialty [2016.09.20]
Title: Even at Cancer Centers, Finding Relief for Pain Can Be Tough
Category: Health News
Created: 9/20/2016 12:00:00 AM
Last Editorial Review: 9/20/2016 12:00:00 AM

more news >>

Clinical Trials Related to Carisoprodol and Aspirin (Carisoprodol / Aspirin)

Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back [Completed]
The purpose of this study is to determine if two sustained released formulations of carisoprodol are more effective than placebo.

A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back [Completed]
The purpose of this study is to determine if two sustained released formulations of carisoprodol are more effective than placebo.

Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis [Completed]
The purpose of this study is to determine whether this topical NF-kappaB Decoy candidate is safe in persons with atopic dermatitis. Preliminary evidence of efficacy (whether it is working) will also be evaluated.

A Comparative Study Between Lysine Clonixinate+Cyclobenzaprine and Caffeine+Carisoprodol+Sodium Diclofenac+Paracetamol [Not yet recruiting]
Non inferiority, multicentric, double blind study whose the primary objective is to compare the effectiveness of two products in pain reduction. Primary endpoint: reduction in pain average at day 7 compared to day 1(baseline), using Analogue Visual Scale (AVS) for pain evaluation. Secondary endpoint: to evaluate the products safety at the gastrointestinal system.

Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy [Recruiting]
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors understand how patients respond to treatment. PURPOSE: This clinical trial is studying biomarkers in patients with rectal cancer undergoing chemotherapy and radiation therapy.

more trials >>


Page last updated: 2016-09-22

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015